PGT-A: GENETIC SCREENING BEFORE EMBRYO TRANSFER
PGT-A, or screening genetic deviation multiple chromosomes (chromosomes) before embryo transfer for the case of performing IVF, is a genetic test carried out on embryos during In Vitro Fertilization (IVF ). PGT-A will provide information about the genetic health of embryos, by screening abnormalities on all 23 pairs of chromosomes. Only embryos with chromosome sets new normal may develop into a healthy baby, PGT-A help team doctors may choose embryos best to transfer and increase the chance of pregnancy success you.
PGT-A laboratory analysis of the number of chromosomes in the embryo IVF.
Embryos abnormal number of chromosomes is the main reason leading to miscarriage in the first 3 months of pregnancy and is the main cause leading to the couple have a child or failure difficult IVF
Embryos with chromosome number of normal chance higher pregnancy success
PGT-A identify embryos with chromosome number of normal and abnormal, so medical team doctor you can select the best embryos to transfer.
Who should implement PGT-A?
PGT-A is appropriate and helpful for the majority of couples who perform IVF
All women are at risk of generating chromosomal abnormal embryos. As women age, the ability to produce chromosomal abnormalities increases significantly.
PGT-A can help women of all ages increase their chances of a successful pregnancy.
All pregnancies are at risk for chromosomal abnormalities. Nearly 50% of embryos produced in an IVF cycle are abnormal embryos in terms of chromosome numbers. Abnormal embryos are one of the main causes of pregnancy difficulties for couples of any age. PGT-A will improve the chances of a successful pregnancy in couples performing IVF. PGT-A is especially suitable for helping couples with recurrent miscarriage, IVF failures, women of high reproductive age (over 35 years), couples with family history deals with chromosomal abnormalities. By selecting healthy embryos with a normal number of chromosomes for transfer, PGT-A:
Improve IVF success rate, increase the likelihood of pregnancy with each transfer
– Reduce the risk of miscarriage
– Reduce risks and complications related to multiple pregnancies
– Avoid childbearing and genetic disorders
– Reduce the cost of doing IVF many times
The results of the PGT-A
GENOME uses the most advanced embryo screening technology available today, providing the most complete picture of chromosome health.
For each embryo analyzed, the PGT-A results will fall into one of three categories: normal, abnormal or mosaic. This information can help your medical team choose the best embryo to perform the transfer.
Why use GENOME PGT-A?
GENOME uses the most advanced new generation gene sequencing (NGS) technology to implement PGT-A. Our NGS platform analyzes thousands of DNA sequences, allowing for precise identification of extra or lost chromosomes. This technology provides extended data analysis capabilities and delivers reliable results. Our test provides the best answer to the patient, ensuring a genetically normal embryo transfer thereby reducing the incidence of miscarriage and birth defects due to chromosome abnormalities.